in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cambridge Major and AAIPharma appoint CEO of merged company
October 31, 2013 | Deepti Ramesh
Cambridge Major Laboratories (CML; Germantown, WI), a producer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs); and AAIPharma Services Corp. (Wilmington, NC), a provider of pharmaceutical analytical testing, product development, and manufacturing services, say that they have appointed Patrick Walsh, the CEO of AAIPharma, as the CEO of the merged company. On 2 October, CML and AAIPharma announced they would merge by the end of October. “The client response to our merger announcement has been very positive,” Walsh says. CML...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee